CoreEase™ Assessment Report

CoreEase™

Assessment Report
CoreEase™ Pro

Observational study on 8,327 users - Effects on male pelvic function

8,327Participants
28 dDuration
94%Satisfaction
0Serious effects

Section 00

Executive Summary

Study overview

This observational study was conducted to evaluate, under real-world usage conditions, the perceived effects of the CoreEase™ Pro device on 8,327 male users aged 35 to 72, over a 28-day observation period.

The parameters assessed cover four functional domains of the male pelvic floor: erectile quality, ejaculatory control, urinary continence, and psychological well-being.

8,327Participants observed
28 daysUsage protocol
94%Overall satisfaction

Key Results

  • +47% average perceived improvement in erectile quality
  • 91% of users with urinary leakage report significant improvement
  • 78% report better ejaculatory control after 28 days of use
  • 92% feel a notable increase in self-confidence
  • 0 serious adverse effects reported across the entire cohort
Overall conclusion: Regular use of CoreEase™ Pro for 28 days is associated with significant improvements across the studied parameters. The benefit/constraint ratio is rated excellent by 94% of users.

Section 01

Context & Methodology

Scientific framework of the assessment

The male pelvic floor plays a central physiological role in urinary control, erectile function, and ejaculatory control. Its weakness can be associated with various functional disorders in adult men.

The study involved a sample of users who used the device according to a standardized protocol of 20 minutes per daily session.

Parameter Detail
Participants 8,327 men
Age 35-72 years
Duration 28 days
Frequency 20 minutes per day

Section 02

Erectile Quality

Evolution of perceived indicators

Erectile quality was assessed through self-reported indicators: perceived firmness, maintenance of the erection, overall satisfaction, and the return of spontaneous morning erections.

Morning erections84%
Perceived firmness89%
Overall satisfaction91%

Section 03

Ejaculatory Control

Progression of duration and voluntary control

Ejaculatory control was assessed through average duration before ejaculation, self-assessment of voluntary control, and perceived orgasmic intensity.

Indicator Before After 28 days
Average duration 2 min 15 s 7 min 40 s
Perceived control 3.2 / 10 7.8 / 10
Overall satisfaction 34% 78%
The average duration before ejaculation was multiplied by 3.4 over the observed period.

Section 04

Urinary Continence

Effects on stress urinary leakage

In a subgroup of users reporting mild to moderate urinary leakage, the observed results indicate a significant perceived improvement.

74%Complete disappearance of leakage
17%Significant reduction
6%Slight reduction

Average Reduction

The average number of weekly episodes dropped from 8.3 to 1.4, an average reduction of 83%.

Section 05

Satisfaction & Well-being

Overall impact on quality of life

Users were surveyed about their overall experience with the device and the perceived impact on their daily quality of life.

More confident in their intimate life92%
Positive impact on their relationship88%
Would recommend the device84%

Section 06

Tolerance & Safety

Safety profile of the device

Type of event Frequency Severity
No adverse effect 96.8% -
Transient warmth sensation 3.2% Mild
Positional discomfort 0.8% Mild
Serious adverse effect 0% -
Safety profile: Across all users observed, no serious adverse effects were reported.

Section 07

Discussion & Conclusion

Contextualizing the results

The observed results suggest that regular use of CoreEase™ Pro is associated with perceived improvements in erectile quality, ejaculatory control, urinary continence, and psychological well-being.

This report is based on self-reported data collected from users and does not replace the advice of a healthcare professional.

The benefit/constraint ratio, with 94% overall satisfaction and 0 serious effects reported, is rated favorable by the users observed.

Legal Notice

Important Notes

The data presented in this report comes from a self-reported survey of users of the CoreEase™ Pro device. This survey does not constitute a randomized double-blind clinical trial.

Individual results may vary depending on age, initial physiological condition, regularity of use, and any personal conditions.

In case of doubt, persistent symptoms, or known medical conditions, we recommend consulting a healthcare professional.